RWA
AZN icon

Redmont Wealth Advisors’s AstraZeneca AZN Stock Holding History

Redmont Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$64.2K Hold
349
– – 0.1% 84
2025
Q3 		$53.6K Hold
349
– – 0.07% 99
2025
Q2 		$48.8K Buy
+349
New +$48.9K 0.07% 100
2024
Q4 		– Sell
-349
Closed -$54.4K – 88
2024
Q3 		$54.4K Hold
349
– – 0.08% 85
2024
Q2 		$54.4K Hold
349
– – 0.09% 84
2024
Q1 		$47.3K Buy
+349
New +$46.2K 0.07% 92

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Redmont Wealth Advisors's AZN Position: Q4 2025 in Review

Redmont Wealth Advisors held its AstraZeneca (AZN) position steady in Q4 2025 at 349 shares worth $64.2K. The position accounts for 0.1% of the portfolio, ranked #84.

Redmont Wealth Advisors first reported a position in AZN in Q1 2024 and has held it in 6 quarters since. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Redmont Wealth Advisors held 349 shares of AstraZeneca worth $64.2K as of Q4 2025.
  • Redmont Wealth Advisors left its AstraZeneca share count unchanged in Q4 2025.
  • AstraZeneca made up 0.1% of Redmont Wealth Advisors's portfolio in Q4 2025, its #84 holding.
  • Redmont Wealth Advisors first reported a position in AstraZeneca in Q1 2024 and has held it in 6 quarters since.
  • 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.